Delivery Order SPE2DB22D3301-SPE2DB25FX9SB
Award Date 2/6/25
Potential Completion Date 2/7/25
Potential Value $1.7K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,155.12, is for the supply of Ultane 250 ML Pen Bottles, a medical product used in healthcare settings. The contract is a Firm Fixed Price arrangement, without any set-aside designation, and has a completion date of February 18, 2025. AmerisourceBergen holds a significant Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is a firm fixed price delivery order for Ultane 250 ML Pen Bottles, a pharmaceutical product, with a ceiling value of $1,250.37 and a period of performance through March 13, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC)...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Ultane 250 ML Pen Bottles. The contract, valued at $1,125.60, is a Firm Fixed Price Delivery Order with an Ultimate Completion Date of April 11, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical valued at up to...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ultane 250 ML pen bottles. This firm fixed-price delivery order, valued at $1,299.51, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), an agreement valued at $999.999 billion through December 2026. The contract involves no set-aside designation and was competitively awarded through...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,688.40 Firm Fixed Price Delivery Order is for the supply of 4561966166 - Ultane 250 ML Pen Bottle 250ML. The contract has an ultimate completion date of August 29, 2023. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is registered in the System for Award Management (SAM.gov) through January 2026. This...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,679.89 on September 17, 2025, for the supply of Ultane 250 ML in pen bottle format. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 18, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This federal contract award, valued at $1,125.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of ULTANE 250 ML PEN BOTTLE 250ML medical products, with a performance period ending on January 10, 2023. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award is not designated with a set-aside requirement, indicating open competition....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,443.90, is for the supply of ULTANE 250 ML PEN BOTTLE 250ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 18, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
- The Defense Logistics Agency awarded a delivery order valued at $3,176.58 to AmerisourceBergen Drug Corp for the supply of Ultane 250 mL pen bottles on September 18, 2025, with an ultimate completion date of September 19, 2025. This non-competitive delivery order utilizes firm fixed pricing and represents a child contract under AmerisourceBergen's larger prime indefinite delivery contract with DLA. The product will be delivered to the company's Conshohocken, Pennsylvania location, where...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract, valued at $2,778.60, is for the provision of ULTANE 250 ML PEN BOTTLE 250ML, a pharmaceutical product. The contract has a period of performance through July 8, 2024 and is a firm fixed-price delivery order, with no set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal...